The biotech industry was at the forefront of vaccine development, which helped us tide over the pandemic. The growth of the biotech industry is driven by government initiatives, rapid technological developments, and the inelastic demand for healthcare.
With the macroeconomic environment expected to remain volatile, biotech companies could prove to be solid investments, given the non-cyclical nature of their businesses. Let’s explore why biotech stocks Amgen Inc. (AMGN), Biogen Inc. (BIIB), and Jazz Pharmaceuticals plc (JAZZ) could rake in big gains this year.
